Asset Details
Do you wish to reserve the book?
Characteristics of medicine use for children with asthma in China: a nationwide population-based study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Characteristics of medicine use for children with asthma in China: a nationwide population-based study
Do you wish to request the book?
Characteristics of medicine use for children with asthma in China: a nationwide population-based study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Characteristics of medicine use for children with asthma in China: a nationwide population-based study
2022
Overview
Objective
To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China.
Methods
The China Healthcare Insurance Research Association (CHIRA) database was searched for children from 0 to 14 years old diagnosed as asthma based on the “J45” and “J46” coded in ICD-10. A cross-sectional study design was employed.
Results
A total of 308,550 children were identified, all of whom were treated under the coverage of healthcare insurance. Among them, 2,468 children were eligible for inclusion in the present study. Compared with the current status of asthma care in European and American countries, under the guidelines for the diagnosis and treatment of asthma in China, the use percentages of ICS and short-acting β
2
receptor agonist in children with asthma in China were lower, but the use percentages of oral corticosteroids, long-acting β
2
receptor agonist, and theophylline (especially intravenous theophylline) were higher, especially in the Central and West China.
Conclusion
The asthma medication use was attributed to many factors, thus efforts are still needed to further popularize the GINA programs and China's guidelines for asthma diagnosis and treatment, especially in the Central and West China.
